January 2, 2025 - 10:32

A local business owner from Raleigh has expressed deep sorrow over the distressing situation unfolding in downtown New Orleans. "You can’t look down any block in this downtown area and not see blue lights or crime tape," she lamented, highlighting the pervasive atmosphere of fear and uncertainty gripping the city.
The recent surge in crime has left many residents and business owners feeling vulnerable and anxious. The sight of flashing blue lights and crime scene tape has become all too common, creating a stark reminder of the challenges facing urban areas today.
As the community grapples with the impact of violence and crime, local leaders and citizens alike are calling for more support and resources to ensure safety. The business owner’s poignant remarks reflect a growing concern among residents who wish to see their neighborhoods return to a place of peace and security. The tragic events have sparked conversations about the need for change and the importance of community resilience in the face of adversity.
January 25, 2026 - 20:36
Minnesota’s Biggest Companies Call for ‘De-escalation’ of TensionsChief executives from several of Minnesota`s largest and most prominent companies, including retail giant Target and agricultural conglomerate Cargill, have jointly issued a public letter calling...
January 25, 2026 - 12:28
Bob on Business: Fort Worth Stock Show with a high-end ‘Landman’ twistThe iconic Fort Worth Stock Show & Rodeo, a century-old celebration of Western heritage, is witnessing a notable shift in its patronage, reflecting the region`s booming energy sector. Observers...
January 24, 2026 - 23:38
How seat-back psychology helped a WA business build a safety card dynastyNestled in Lacey, Washington, a quiet manufacturing success story has been unfolding for decades, one airplane seat-back pocket at a time. A local company has become an unlikely dynasty, producing...
January 24, 2026 - 02:33
Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trialsThe pharmaceutical company Moderna is scaling back its plans to invest in new late-stage clinical trials for infectious disease vaccines, citing a challenging environment. A significant factor in...